Secondary hyperparathyroidism (SHPT) affects a majority of patients with chronic kidney
disease (CKD) of stage 3 or worse. Despite the development of calcimimetics and their …

Secondary hyperparathyroidism (SHPT) and tertiary hyperparathyroidism (THPT) are
common and complicated clinical endocrine diseases. The parathyroid glands maintain …

Objective: To develop evidence-based recommendations for safe, effective, and appropriate
treatment of secondary (SHPT) and tertiary (THPT) renal hyperparathyroidism. Background …

Chronic kidney disease mineral and bone disorder may persist after successful kidney
transplantation. Persistent hyperparathyroidism has been identified in up to 80% of patients …

Chronic kidney disease–mineral and bone disorder is one of the complications associated
with chronic kidney disease. About 10–50% of patients following kidney transplantation …

Renal hyperparathyroidism (rHPT) is a complex and challenging disorder. It develops early
in the course of renal failure, and is associated with increased risks of fractures …

Kidney transplantation remains the best treatment for patients with end-stage kidney
disease, and it could partially mitigate systemic disorders of mineral and bone metabolism …

Parathyroidectomy (PTX) remains an important intervention for dialysis patients with poorly
controlled secondary hyperparathyroidism (SHPT), though there are only retrospective and …

Background: Surgery for irreversible hyperparathyroidism is the preferred management for
kidney transplant patients. The authors analyzed the factors associated with persistent …

Background Prevalence of uremic hyperparathyroidism (uHPT), secondary and tertiary,
continues to rise. Historically, surgery was the only durable treatment for these conditions …